Physicochemical cargo-switching nanoparticles (CSNP) designed by KAIST can help significantly reduce cholesterol and macrophage foam cells in arteries, which are the two main triggers for atherosclerotic plaque and inflammation.
Click here for original story, New nanoparticle drug combination for atherosclerosis developed
Source: Phys.org